Home > News

Follow Us

A cure for type 1 diabetes

Read about the novel clinical study.

Diabetes researcher Denis Faustman, MD, PhD and colleagues at Massachusetts General Hospital (MGH) are using Mercodia´s C-Peptide kits in a novel type 1 diabetes clinical study.

The trial is testing whether using a generic drug to temporarily elevate tumor necrosis factor-alpha (TNF-a) levels in the body will reduce or eliminate autoimmune T cells in patients with established type 1 diabetes, an approach based on the Faustman lab’s previous success in reversing end-stage diabetes in mice. To learn more, please visit www.faustmanlab.org  www.faustmanlab.org


Additional Links of Interest

Listen as Dr. Faustman describes her own research in "EFTR: Targeting Diabetes with an Old TB Vaccine"


02/26/15 Glucagon and insulin secretion measured in healthy cats

02/11/15 Wear Red Day - Fight Heart Disease in Women.

12/18/14 Coffee increases the risk for diabetes in offspring

12/10/14 Mercodia supports birds of prey rescue center: Sky Hunters California

12/05/14 Pig islets are one step closer to xenotransplantation

11/18/14 Encapsulated embryonic stem cells may be an effective and safe cell replacement

More news and archive | Return | Print